Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort
<p><strong>Introduction</strong> Invasive non-typhoidal Salmonellosis (iNTS) is mainly caused by <i>Salmonella enterica</i> serovars Typhimurium and Enteritidis and is estimated to result in 77 500 deaths per year, disproportionately affecting children under 5 years of...
Main Authors: | Hanumunthadu, B, Kanji, N, Owino, N, Ferreira Da Silva, C, Robinson, H, White, R, Ferruzzi, P, Nakakana, U, Canals, R, Pollard, AJ, Ramasamy, M |
---|---|
Other Authors: | Vacc-iNTS Consortium |
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2023
|
Similar Items
-
Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort
by: Melita A Gordon, et al.
Published: (2023-11-01) -
Safety and immunogenicity of the iNTS-GMMA vaccine
by: Hanumunthadu, B
Published: (2023) -
The iNTS-GMMA vaccine: a promising step in non-typhoidal Salmonella vaccine development
by: Peter D Skidmore, et al.
Published: (2023-12-01) -
Towards a Four-Component GMMA-Based Vaccine against <i>Shigella</i>
by: Francesca Micoli, et al.
Published: (2022-02-01) -
Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine
by: Jianlong Lou, et al.
Published: (2018-11-01)